Since TaiHao medical establishment in 2013, Taihao medical has been focusing on the development of AI medical imaging software. It uses medical imaging AI to assist doctors or radiologists to more effectively interpret medical images generated by ultrasound and LDCT, while also greatly improving the quality of medical care. and improve clinical efficiency and reduce workload. We also cooperate with major medical centers and academic research institutions to continuously improve and optimize our AI technology and products.

TaiHao AI software functions include image analysis, automatic detection, auxiliary diagnosis, reporting system, etc. High accuracy and efficiency can help doctors judge the condition more quickly and accurately and complete diagnostic reports. Whether you are a medical professional or a researcher, we can provide the most appropriate solution for your needs.

Currently, TaiHao Medical has outstanding achievements in the field of breast ultrasound screening and diagnosis. In 2020, it obtained Japan's first medical material license for breast ultrasound AI-assisted screening, and in 2021 it was also the first to obtain US FDA's AI license for breast ultrasound lesion detection and diagnosis. The field of AI is at the forefront of the world.

We firmly believe that the power of technology can change the future of the medical industry. Through the power of artificial intelligence, we provide medical professionals with advanced medical imaging solutions to help doctors and medical institutions improve accuracy and efficiency, reduce the burden on medical personnel, and improve patients' medical experience. Then improve the current situation of the medical industry, benefit more patients, and continuously improv our standards.

If you have any questions or need help, please feel free to contact us. Our customer service team is here to provide support and assistance.